查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599205

全球管道切割市場：按藥物、類型、患者和最終用戶分類 - 2025-2030 年預測

Vasectomy Market by Drug (Anesthetics, Antibiotics, Painkillers), Type (Conventional, Minimally Invasive, No-Scalpel), Patient, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

據預測，2023年管道切割市場價值為196.3億美元，預計到2024年將達到211.6億美元，複合年成長率為7.89%，到2030年將達到334.1億美元。

輸精管切除術是男性節育手術的外科手術，是切割或封閉輸精管以防止精子進入射精。輸精管結紮術的需求源於其作為永久性避孕方法的有效性，並為計劃生育提供了可靠的解決方案。該手術主要針對尋求長期節育方法的男性。最終用途範圍包括醫療機構，例如診所、醫院和進行管道切割的門診手術中心。由於多種影響因素，例如男性避孕選擇意識的提高、對有效和永久避孕方法的需求不斷成長以及對計劃生育共用責任的日益重視，輸精管結紮術市場正在擴大。此外，微創手術技術的進步可以提高手術安全性並提高接受率和採用率。潛在的機會也存在於意識和機會仍然較低的新興市場，為擴大教育和服務提供了機會。開拓具有成本效益、侵入性較小的手術可以吸引猶豫人群的注意力並提高市場滲透率。然而，文化阻力、某些地區認知度低以及對該程序的誤解等限制可能會給市場成長帶來挑戰。最重要的創新在於增強技術以盡量減少恢復時間和不適，以及加強教育以降低男性對避孕方法的參與。另一個潛在的研究領域是輸精管結紮術對患者的心理影響。隨著越來越多的男性認知到輸精管結紮術作為計劃生育綜合方法的一部分的好處，輸精管結紮術市場的性質正在逐漸轉向更廣泛的接受度。投資教育宣傳活動和技術進步的公司將在這個不斷擴大的領域擁有競爭優勢。

主要市場統計
基準年[2023] 196.3億美元
預測年份 [2024] 211.6億美元
預測年份 [2030] 334.1億美元
複合年成長率（%） 7.89%

市場動態：揭示快速發展的管道切割市場的關鍵市場洞察

供需的動態交互作用正在改變管材切割市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 政府不斷採取措施來提高人們對管道切割的認知
    • 政府努力提高對男性節育手術的認知
  • 市場限制因素
    • 與切管手術相關的風險
  • 市場機會
    • 由於技術進步，研發活動投資增加
  • 市場挑戰
    • 發展中地區的意識低落與社會禁忌

波特五力：駕馭管材切割市場的策略工具

波特的五力框架是了解管線切割市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解管道切割市場的外部影響

外部宏觀環境因素對管材切割市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解管材切割市場的競爭狀況

對管道切割市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣切管市場供應商績效評估

FPNV定位矩陣是評估管材切割市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製管道切割市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對管道切割市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府不斷努力提高人們對管道切割的認知
      • 政府努力提高對男性節育手術的認知
    • 抑制因素
      • 與切管手術相關的風險
    • 機會
      • 隨著技術進步，增加投資以促進研發活動
    • 任務
      • 發展中地區的意識低落與社會禁忌
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥物切管市場

  • 麻醉劑
  • 抗生素
  • 止痛藥

第7章管材切割市場：依類型

  • 傳統的
  • 微創
  • 沒有手術刀

第8章患者切管市場

  • 動物
  • 人類

第9章管道切割市場：依最終用戶分類

  • 醫院/診所
  • 研究和學術

第10章 北美和南美管道切割市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太切管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲管道切割市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Accurate Surgical & Scientific Instruments Corporation
  • Advanced Meditech International
  • Bayer AG
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Kapp Surgical Instrument Inc.
  • McKesson Medical-Surgical Inc.
  • Novartis AG
  • PARAGON MEDICAL SUPPLY, INC.
  • Pfizer, Inc.
  • Sanofi SA
  • Sklar Surgical Instruments
  • Surtex Instruments Limited
  • Wexler Surgical, Inc.
Product Code: MRR-0307E66790F4

The Vasectomy Market was valued at USD 19.63 billion in 2023, expected to reach USD 21.16 billion in 2024, and is projected to grow at a CAGR of 7.89%, to USD 33.41 billion by 2030.

Vasectomy, a surgical procedure for male sterilization, involves cutting or sealing the vas deferens to prevent sperm from entering the ejaculate. The necessity of vasectomies arises from their effectiveness as a permanent form of contraception, providing a reliable solution for family planning. This procedure primarily finds application in men seeking long-term birth control solutions. The end-use scope encompasses healthcare facilities, including clinics, hospitals, and outpatient surgical centers, where vasectomies are performed. The market for vasectomy is expanding due to several influencing factors: increasing awareness about male contraceptive options, rising demand for effective and permanent birth control methods, and the growing emphasis on shared responsibility in family planning. Additionally, advancements in minimally invasive surgical techniques have improved the procedure's safety, potentially boosting acceptance and adoption rates. Potential opportunities exist in emerging markets where awareness and access remain lower, offering a chance to educate and expand services. Developing cost-effective, less invasive procedures may also capture the attention of hesitant demographics, enhancing market penetration. However, limitations such as cultural resistance, limited awareness in some regions, and misconceptions about the procedure can pose challenges to market growth. The most significant innovations lie in enhancing procedural techniques to minimize recovery time and discomfort, as well as increasing educational outreach to destigmatize male involvement in contraceptive methods. Another potential area of research is the psychological impact of vasectomy on patients, which can address concerns and improve satisfaction post-procedure. The nature of the vasectomy market is gradually shifting towards increasing acceptance as more men recognize its benefits as part of a comprehensive approach to family planning. Companies that invest in educational campaigns and technological advancements stand to gain a competitive edge in this expanding field.

KEY MARKET STATISTICS
Base Year [2023] USD 19.63 billion
Estimated Year [2024] USD 21.16 billion
Forecast Year [2030] USD 33.41 billion
CAGR (%) 7.89%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vasectomy Market

The Vasectomy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government initiatives to promote awareness about the vasectomy
    • Government initiatives raising awareness about male sterilization
  • Market Restraints
    • Risk associated with vasectomy surgeries
  • Market Opportunities
    • Increased investments to boost the research and development activities along with technological advancement
  • Market Challenges
    • Limited awareness and social taboo in developing regions

Porter's Five Forces: A Strategic Tool for Navigating the Vasectomy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vasectomy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vasectomy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vasectomy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vasectomy Market

A detailed market share analysis in the Vasectomy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vasectomy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vasectomy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vasectomy Market

A strategic analysis of the Vasectomy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vasectomy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accurate Surgical & Scientific Instruments Corporation, Advanced Meditech International, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Kapp Surgical Instrument Inc., McKesson Medical-Surgical Inc., Novartis AG, PARAGON MEDICAL SUPPLY, INC., Pfizer, Inc., Sanofi S.A., Sklar Surgical Instruments, Surtex Instruments Limited, and Wexler Surgical, Inc..

Market Segmentation & Coverage

This research report categorizes the Vasectomy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug, market is studied across Anesthetics, Antibiotics, and Painkillers.
  • Based on Type, market is studied across Conventional, Minimally Invasive, and No-Scalpel.
  • Based on Patient, market is studied across Animal and Human.
  • Based on End-User, market is studied across Hospital & Clinic and Research & Academic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government initiatives to promote awareness about the vasectomy
      • 5.1.1.2. Government initiatives raising awareness about male sterilization
    • 5.1.2. Restraints
      • 5.1.2.1. Risk associated with vasectomy surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased investments to boost the research and development activities along with technological advancement
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and social taboo in developing regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vasectomy Market, by Drug

  • 6.1. Introduction
  • 6.2. Anesthetics
  • 6.3. Antibiotics
  • 6.4. Painkillers

7. Vasectomy Market, by Type

  • 7.1. Introduction
  • 7.2. Conventional
  • 7.3. Minimally Invasive
  • 7.4. No-Scalpel

8. Vasectomy Market, by Patient

  • 8.1. Introduction
  • 8.2. Animal
  • 8.3. Human

9. Vasectomy Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospital & Clinic
  • 9.3. Research & Academic

10. Americas Vasectomy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vasectomy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vasectomy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accurate Surgical & Scientific Instruments Corporation
  • 3. Advanced Meditech International
  • 4. Bayer AG
  • 5. Bristol Myers Squibb Company
  • 6. Eli Lilly and Company
  • 7. GlaxoSmithKline plc
  • 8. Kapp Surgical Instrument Inc.
  • 9. McKesson Medical-Surgical Inc.
  • 10. Novartis AG
  • 11. PARAGON MEDICAL SUPPLY, INC.
  • 12. Pfizer, Inc.
  • 13. Sanofi S.A.
  • 14. Sklar Surgical Instruments
  • 15. Surtex Instruments Limited
  • 16. Wexler Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. VASECTOMY MARKET RESEARCH PROCESS
  • FIGURE 2. VASECTOMY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASECTOMY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASECTOMY MARKET DYNAMICS
  • TABLE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASECTOMY MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASECTOMY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASECTOMY MARKET SIZE, BY PAINKILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASECTOMY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASECTOMY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASECTOMY MARKET SIZE, BY NO-SCALPEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASECTOMY MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASECTOMY MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASECTOMY MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASECTOMY MARKET SIZE, BY RESEARCH & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023